Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Century Shenkang Pharmaceutical Industry is a high-tech Chinese pharmaceutical company specializing in the research, development, and production of treatments for chronic kidney disease (CKD). Founded in 2007 and headquartered in Xi'an, the company is best known for its flagship product, Shenkang Injection (SKI), a modern traditional Chinese medicine (TCM) preparation approved in 2004 and included in the National Medical Insurance Catalog. The company also produces Shenkang Suppository and is actively engaged in the development of innovative drugs with independent intellectual property rights. Its manufacturing facilities are GMP-certified and located in the Fengjing Industrial Park. Century Shenkang has consistently ranked among the top 100 Chinese traditional medicine enterprises and is recognized as a Specialized and Sophisticated SME in Shaanxi Province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Century Shenkang Pharmaceutical Industry.